OBJECTIVE: To explore the associations between self reported high risk sexual behaviours and subsequent diagnosis with hepatitis C virus (HCV) infection. METHODS: The Sex, Health and Anti-Retrovirals Project (SHARP) was a cross sectional study of sexual behaviour in HIV positive, men who have sex with men (MSM) attending a London outpatient clinic. From July 1999 to August 2000 participants completed a computer assisted self interview questionnaire (CASI) on recent sexual behaviour, recreational drug use, and detailed reporting of the last two sexual episodes involving different partners. Results were combined with routine clinic data and subsequent testing for HCV up to 21 April 2005. A new HCV diagnosis was defined as anti-HCV antibody seroconversion or positive HCV RNA following a previous negative. Incident rate ratios (IRR) were calculated using Poisson regression in Stata (version 9). Men contributed time at risk from interview until either their diagnosis or their last negative test result. RESULTS: Of the 422 men who completed questionnaires, 308 (73%) had sufficient clinical and HCV testing data available for analysis. Incident HCV infection was identified in 11 men. Unprotected anal intercourse, more than 30 sex partners in the past year, higher numbers of new anal sex partners, rimming (oro-anal sex), fisting, use of sex toys, and intranasal recreational drug use were associated with HCV. In multivariate analysis only fisting remained associated with HCV (adjusted IRR 6.27, p = 0.005). CONCLUSIONS: In this study of HIV positive MSM, fisting is strongly associated with HCV infection. Where individuals report high risk sexual behaviours, clinicians should offer appropriate testing for HCV infection.
OBJECTIVE: To explore the associations between self reported high risk sexual behaviours and subsequent diagnosis with hepatitis C virus (HCV) infection. METHODS: The Sex, Health and Anti-Retrovirals Project (SHARP) was a cross sectional study of sexual behaviour in HIV positive, men who have sex with men (MSM) attending a London outpatient clinic. From July 1999 to August 2000 participants completed a computer assisted self interview questionnaire (CASI) on recent sexual behaviour, recreational drug use, and detailed reporting of the last two sexual episodes involving different partners. Results were combined with routine clinic data and subsequent testing for HCV up to 21 April 2005. A new HCV diagnosis was defined as anti-HCV antibody seroconversion or positive HCV RNA following a previous negative. Incident rate ratios (IRR) were calculated using Poisson regression in Stata (version 9). Men contributed time at risk from interview until either their diagnosis or their last negative test result. RESULTS: Of the 422 men who completed questionnaires, 308 (73%) had sufficient clinical and HCV testing data available for analysis. Incident HCV infection was identified in 11 men. Unprotected anal intercourse, more than 30 sex partners in the past year, higher numbers of new anal sex partners, rimming (oro-anal sex), fisting, use of sex toys, and intranasal recreational drug use were associated with HCV. In multivariate analysis only fisting remained associated with HCV (adjusted IRR 6.27, p = 0.005). CONCLUSIONS: In this study of HIV positive MSM, fisting is strongly associated with HCV infection. Where individuals report high risk sexual behaviours, clinicians should offer appropriate testing for HCV infection.
Authors: E Jaeckel; M Cornberg; H Wedemeyer; T Santantonio; J Mayer; M Zankel; G Pastore; M Dietrich; C Trautwein; M P Manns Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Hannelore M Götz; Gerard van Doornum; Hubert Gm Niesters; Jan G den Hollander; H Bing Thio; Onno de Zwart Journal: AIDS Date: 2005-06-10 Impact factor: 4.177
Authors: Yvonne C Gilleece; Rita E Browne; David Asboe; Mark Atkins; Sundhiya Mandalia; Mark Bower; Brian G Gazzard; Mark R Nelson Journal: J Acquir Immune Defic Syndr Date: 2005-09-01 Impact factor: 3.731
Authors: L Gambotti; D Batisse; N Colin-de-Verdiere; E Delaroque-Astagneau; J C Desenclos; S Dominguez; C Dupont; X Duval; A Gervais; J Ghosn; C Larsen; S Pol; J Serpaggi; A Simon; M A Valantin; A Velter Journal: Euro Surveill Date: 2005-05
Authors: J M Stephenson; J Imrie; M M D Davis; C Mercer; S Black; A J Copas; G J Hart; O R Davidson; I G Williams Journal: Sex Transm Infect Date: 2003-02 Impact factor: 3.519
Authors: M A Balogun; M E Ramsay; J V Parry; L Donovan; N J Andrews; J A Newham; C McGarrigle; K A Harris; C G Teo Journal: Sex Transm Infect Date: 2003-08 Impact factor: 3.519
Authors: Cara E Rice; Courtney Maierhofer; Karen S Fields; Melissa Ervin; Stephanie T Lanza; Abigail Norris Turner Journal: J Sex Med Date: 2016-02-04 Impact factor: 3.802
Authors: Mallory D Witt; Eric C Seaberg; Annie Darilay; Stephen Young; Sheila Badri; Charles R Rinaldo; Lisa P Jacobson; Roger Detels; Chloe L Thio Journal: Clin Infect Dis Date: 2013-03-26 Impact factor: 9.079
Authors: E Orsetti; S Staffolani; R Gesuita; G De Iaco; E Marchionni; L Brescini; P Castelli; F Barchiesi Journal: Infection Date: 2013-05-24 Impact factor: 3.553